Skip to main content

Advertisement

Log in

The comparative effectiveness of methotrexate and anti-tumor necrosis factor therapy in psoriatic arthritis

  • Clinical Trials Report
  • Published:
Current Rheumatology Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. O’Dell JR: Therapeutic strategies for rheumatoid arthritis. N Engl J Med 2004, 350: 2591–2602.

    Article  PubMed  CAS  Google Scholar 

  2. Heydendael VMR, Spuls PI, Opmeer BC, et al.: Methotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasis. N Engl J Med 2003, 349: 658–665.

    Article  PubMed  CAS  Google Scholar 

  3. Black R, Obrien W, Vanscott E, et al.: Methotrexate therapy in psoriatic arthritis, double-blind study in 21 patients. JAMA 1964, 189: 743–747.

    PubMed  CAS  Google Scholar 

  4. Willkens RF, Williams HJ, Ward JR, et al.: Randomized, double-blind, placebo controlled trial of low-dose pulse methotrexate in psoriatic arthritis. Arthritis Rheum 1984, 27: 376–381.

    Article  PubMed  CAS  Google Scholar 

  5. Soriano ER, McHugh NJ: Therapies for peripheral joint disease in psoriatic arthritis. A systematic review. J Rheumatol 2006, 33: 1422–1430.

    PubMed  Google Scholar 

  6. Kavanaugh AF, Ritchlin CT, the GRAPPA Treatment Guidelines Committee: Systematic review of treatments for psoriatic arthritis: an evidence based approach and basis for treatment guidelines. J Rheumatol 2006, 33: 1417–1421.

    PubMed  Google Scholar 

  7. Kane D, Stafford L, Bresnihan B, FitzGerald O: A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience. Rheumatology 2003, 42: 1460–1468.

    Article  PubMed  CAS  Google Scholar 

  8. Heiberg MS, Koldingsnes W, Mikkelsen K, et al.: The comparative one-year performance of anti-tumor necrosis factor alpha drugs in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: results from a longitudinal, observational, multicenter study. Arthritis Rheum 2008, 59: 234–240.

    Article  PubMed  CAS  Google Scholar 

  9. Klareskog L, van der Heijde D, de Jager JP, et al.: Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial. Lancet 2004, 363: 675–681.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ritchlin, C.T. The comparative effectiveness of methotrexate and anti-tumor necrosis factor therapy in psoriatic arthritis. Curr Rheumatol Rep 10, 295–296 (2008). https://doi.org/10.1007/s11926-008-0047-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11926-008-0047-0

Keywords

Navigation